Health Economics Unit, University of Birmingham, Birmingham, UK.
Br J Cancer. 2013 Nov 12;109(10):2533-47. doi: 10.1038/bjc.2013.631. Epub 2013 Oct 15.
This study examines the cost-effectiveness of sentinel lymph node biopsy, a potentially less morbid procedure, compared with inguinofemoral lymphadenectomy (IFL) among women with stage I and stage II vulval squamous cell carcinoma.
A model-based economic evaluation was undertaken based on clinical evidence from a systematic review of published sources. A decision tree model was developed with the structure being informed by clinical input, taking the perspective of the health-care provider.
For overall survival for 2 years, IFL was found to be the most cost-effective option and dominated all other strategies, being the least costly and most effective. For morbidity-free related outcomes for 2 years, sentinel lymph node (SLN) biopsy with 99mTc and blue dye and haematoxylin & eosin (H&E) histopathology, with ultrastaging and immunohistochemistry reserved for those that test negative following H&E is likely to be the most effective approach.
SLN biopsy using 99mTc and blue dye with ultrastaging may be considered the most cost-effective strategy based on the outcome of survival free of morbidity for 2 years. The findings here also indicate that using blue dye and H&E for the identification of the SLN and the identification of metastasis, respectively, are not sensitive enough to be used on their own.
本研究考察了前哨淋巴结活检的成本效益,与 IFL 相比,前哨淋巴结活检在 I 期和 II 期外阴鳞癌患者中具有潜在的较低的发病率。
基于系统评价中发表文献的临床证据,进行了基于模型的经济评估。开发了一个决策树模型,其结构由临床输入提供信息,并从医疗保健提供者的角度出发。
对于 2 年的总生存率,IFL 被认为是最具成本效益的选择,并且优于所有其他策略,因为它的成本最低,效果最佳。对于 2 年无病相关结果,99mTc 和蓝染料联合苏木精和伊红(H&E)组织病理学的前哨淋巴结(SLN)活检,对于 H&E 检测阴性的患者保留超微结构检查和免疫组织化学检查,可能是最有效的方法。
基于 2 年无病生存的结果,使用 99mTc 和蓝染料联合超微结构检查的 SLN 活检可能被认为是最具成本效益的策略。这里的研究结果还表明,单独使用蓝染料和 H&E 分别识别 SLN 和转移灶的敏感性不够高。